首页> 外文期刊>Journal of vascular surgery >Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes.
【24h】

Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes.

机译:在美国,完整的胸腹主动脉瘤的手术治疗:医院和外科医生量相关的结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Surgical treatment of intact thoracoabdominal aortic aneurysm (TAAA) is crucial to prevent rupture but is associated with high perioperative mortality. We tested the hypothesis that provider volume of surgical treatment of TAAA is an important determinant of operative outcome.Patients and methods Clinical information regarding repair of intact TAAA in 1542 patients from 1988 to 1998 was obtained from the Nationwide Inpatient Sample (NIS), a stratified discharge database of a representative 20% of US hospitals. Demographic data included age, sex, race, nature of admission, and comorbid conditions. Annual hospital volume of TAAA treated was grouped into terciles and defined as low (LVH; 1-3 cases [median, 1]), medium (MVH; 2-9 cases [median, 4]), or high (HVH; 5-31 cases [median, 12]). Annual surgeon volume was defined as low (LVS; 1-2 cases [median, 1]) or high (HVS; 3-18 cases [median, 7]). The primary outcome measure was in-hospital postoperative mortality. Secondary outcome measures included length of stay, and cardiac, pulmonary, and renal complications. Adjusted and unadjusted analyses were conducted. RESULTS: Overall mortality was 22.3%. Mortality improved over time. LVH and HVH differed in mortality rates (27.4% vs 15.0%; P <.001). Mortality between LVS and HVS also differed significantly (25.6% vs 11.0%; P <.001). When controlling for patient demographic data, comorbid conditions, and postoperative complications, both hospital and surgeon volume were significant predictors of mortality for intact TAAA repair (LVS: odds ratio [OR] 2.6, P <.001; LVH: OR 2.2, P <.001; and MVH: OR 1.7, P =.004). CONCLUSIONS: Greater hospital and surgeon TAAA treatment volumes contribute to better outcome. Given the relative high perioperative mortality associated with TAAA repair, regionalization of care to high-volume providers with consistently lower postoperative mortality deserves consideration by patients, physicians, and health care planners.
机译:目的:完整的胸腹主动脉瘤(TAAA)的外科手术治疗对于预防破裂至关重要,但其围手术期死亡率高。我们检验了以下假设:手术治疗的TAAA的提供者数量是决定手术结局的重要因素。患者和方法从全国住院患者样本(NIS)中获得了1988年至1998年间1542例患者完整TAAA修复的临床信息。代表美国20%医院的出院数据库。人口统计数据包括年龄,性别,种族,入学性质和合并症。 TAAA的年度医院治疗量分为三类,分别为低(LVH; 1-3例[中位数,1]),中(MVH; 2-9例[中位数,4])或高(HVH; 5- 31例[中位数,12]。年度外科医生人数定义为低(LVS; 1-2例[中位数,1])或高(HVS; 3-18例[中位数,7])。主要结果指标是院内术后死亡率。次要结果指标包括住院时间,心脏,肺和肾脏并发症。进行了调整和未调整的分析。结果:总死亡率为22.3%。死亡率随着时间的推移而改善。 LVH和HVH的死亡率不同(27.4%对15.0%; P <.001)。 LVS和HVS之间的死亡率也有显着差异(25.6%对11.0%; P <.001)。在控制患者的人口统计学数据,合并症和术后并发症时,医院和手术医生的人数都是完整TAAA修复死亡率的重要预测指标(LVS:优势比[OR] 2.6,P <.001; LVH:OR 2.2,P < .001; MVH:OR 1.7,P = .004)。结论:更大的医院和外科医生的TAAA治疗量有助于更好的预后。考虑到与TAAA修复相关的围手术期相对较高的死亡率,应向患者,医师和卫生保健计划者考虑,将手术区域划分为术后死亡率一直较低的大剂量医疗机构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号